LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – IDEXX Laboratories, Inc. Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$49.87M
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
-7.11%
quarter
IDEXX Laboratories, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.26% | 398 shares | -3.67M | $325.8 | 153.07K |
| Q2 2022 | share | Increase | +0.36% | 542 shares | -29.68M | $350.73 | 152.68K |
| Q1 2022 | share | Decrease | -0.16% | -241 shares | -17.10M | $547.06 | 152.13K |
| Q4 2021 | share | Decrease | -1.06% | -1.62K shares | 4.55M | $661.32 | 152.38K |
| Q3 2021 | share | Decrease | -0.13% | -193 shares | -1.60M | $621.9 | 154.00K |
| Q2 2021 | share | Increase | +3.00% | 4.49K shares | 24.13M | $631.55 | 154.2K |
| Q1 2021 | share | Increase | +1.26% | 1.86K shares | -646K | $489.31 | 149.70K |
| Q4 2020 | share | Increase | +0.14% | 202 shares | 15.86M | $499.87 | 147.83K |
| Q3 2020 | share | Decrease | -0.08% | -117 shares | 9.25M | $393.11 | 147.63K |
| Q2 2020 | share | Decrease | -0.42% | -624 shares | 12.84M | $330.16 | 147.75K |
| Q1 2020 | share | Increase | +1.25% | 1.82K shares | -2.32M | $242.24 | 148.37K |
| Q4 2019 | share | Increase | +0.32% | 465 shares | -1.45M | $261.13 | 146.54K |
| Q3 2019 | share | Decrease | -0.57% | -841 shares | -729K | $271.93 | 146.08K |
| Q2 2019 | share | Decrease | -0.21% | -310 shares | 7.53M | $275.33 | 146.92K |
| Q1 2019 | share | Increase | +1.09% | 1.58K shares | 5.82M | $223.6 | 147.23K |
| Q4 2018 | share | Increase | +6.49% | 8.87K shares | -7.05M | $186.02 | 145.65K |
| Q3 2018 | share | Decrease | -0.24% | -328 shares | 4.26M | $249.66 | 136.77K |
| Q2 2018 | share | Decrease | -1.55% | -2.15K shares | 3.22M | $217.94 | 137.10K |
| Q1 2018 | share | Decrease | -0.29% | -405 shares | 4.81M | $191.39 | 139.26K |
| Q4 2017 | share | Decrease | -1.05% | -1.48K shares | -106K | $156.38 | 139.66K |
| Q3 2017 | share | Increase | 0.00% | 4 shares | -1.54M | $155.49 | 141.14K |
| Q2 2017 | share | Decrease | -9.40% | -14.65K shares | -593K | $161.42 | 141.14K |
| Q1 2017 | share | Decrease | -12.96% | -23.19K shares | 3.09M | $154.61 | 155.79K |
| Q4 2016 | share | Decrease | -19.47% | -43.27K shares | -4.06M | $117.27 | 178.98K |
| Q3 2016 | share | Decrease | -8.39% | -20.34K shares | 2.52M | $112.73 | 222.25K |
| Q2 2016 | share | Increase | +0.77% | 1.85K shares | 3.67M | $92.86 | 242.60K |
| Q1 2016 | share | Increase | +4.09% | 9.46K shares | 1.99M | $78.32 | 240.75K |